Expert Insights on Clinical Research
Clinical Research is the study of experimental therapies in human volunteers. Also referred to as clinical trials, clinical research is often funded by the NIH and/or pharmaceutical companies and regulated by the Food and Drug Administration within the United States. The purpose of clinical research is to study the safety and efficacy of therapies against a control such as a placebo or an existing, approved therapy.
Gerson Lehrman Group Council Members are available to discuss Clinical Research via phone consultations, live meetings, surveys, and other custom GLG products and services.
Find, engage, and manageSM experts today through the GLG platform
Featured Council Members
GLG Council Members are leading experts including academics, scientists, and industry specialists
-
Daniel Wynn, MD
Director of Clinical ResearchCONSULTANTS IN NEUROLOGY LTD
-
Warren Botnick, MD
PresidentPSS Clinical Research
-
Jeffrey Weinberg
Director of Clinical Research - DermatologyST LUKE'S-ROOSEVELT HOSPITAL CENTER
-
Mark Vandewalker, MD
Allergy Specialist and PartnerAllergy & Asthma Consultants Of The Ozarks Ltd
-
Charles Ryan, MD
Associate Professor of MedicineUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Study Groups
Study groups are populations of experts knowledgeable on specific sub-topics within a broader industry
Recent Live Meetings
Interactive roundtables, private visits, and small scale seminars are types of GLG Live Meetings
-
July 23, 2009 | Webcast
Webcast: Discerning Hype from Substance in Clinical Trials (11:00 AM EDT / 16:00 BST) -
September 22, 2009 | Boston
Seminar: Current Issues in Monitoring Clinical Trials with Thomas Fleming, PhD (Boston) -
September 24, 2009 | New York
Seminar: Current Issues in Monitoring Clinical Trials with Thomas Fleming, PhD (New York) -
September 15, 2009 | San Francisco
Seminar: Current Issues in Monitoring Clinical Trials with Thomas Fleming, PhD (San Francisco) -
November 16, 2009 | Hong Kong
Seminar: Changes in U.S. Drug Regulation Change the Prognosis for Industry (Hong Kong)
Recent News Analyses
News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations
-
Starpharma gets US patent for use of VivaGel for protection against STIs
September 29, 2009
Jeffrey Weinberg, Director of Clinical Research - Dermatology, ST LUKE'S-ROOSEVELT HOSPITAL CENTER
Starpharma gets US patent for use of VivaGel for protection against STIs | www.pharmabiz.com
Starpharma's lead product, is a vaginal microbicide gel under development for the prevention of sexually transmitted infections (STIs), including genital herpes and HIV infection. The VivaGel® product concept is designed to offer a safe, convenient and affordable means for women to protect themselves...
-
Stelara new Option for Psoriasis
September 26, 2009
Jeffrey Weinberg, Director of Clinical Research - Dermatology, ST LUKE'S-ROOSEVELT HOSPITAL CENTER
Stelara Approved to Treat Moderate to Severe Plaque Psoriasis in Adults | www.webmd.com
The FDA approved Stelara based on three studies of 2,266 patients who either got shots of Stelara or a placebo. Patients who got Stelara were more likely to achieve the studies' benchmark for reduction in psoriasis.In a news release, the FDA notes that because Stelara reduces the immune system's ability...
-
India is a good clinical trial destination with new CROs in future
September 27, 2009
Growing pharma market makes India a clinical trial destination: Report | www.thehindubusinessline.com
Pharmaceutical boom in India has opened up the doors of new clinical trials due to various factors, like new research & treatment avenues, which can be explored best in Indian Clinical Trials due to ease of carrying out Clinical trials in india, which is also giving birth to new CROs.
-
New hopes for Influenza Prevention & treatment
September 29, 2009
Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment | www.pipelinereview.com
Joint Strategic Collaboration between Johnson & Johnson and Crucell for influenza prevention and Treatment can open up new avenues by joint Joint research & clinical Trial programmes.
-
Pharma Outsourcing: Where Will it End?
November 3, 2009
Quintiles inks pharma deals | www.outsourcing-pharma.com
A major supplier of clinical development services has just been awarded all of Astra Zeneca's clinical pharmacology work. Such work was traditionally performed internally but is now one of many stages of development being outsourced. This follows similar trends in research, where pharma companies are...